Mineralys Therapeutics, Inc.
MLYS
Revenue
0.00
0.000.00%
-Assets
599.95M
▲264.22M▲78.70%
3 Months ChangeLiabilities
23.52M
▲1.35M▲6.07%
3 Months ChangeFree Cash Flow
-45.49M
▼-26.29M▼-136.94%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001933414-26-000048
2026-01-06
Form 8-K
ID: 0001933414-26-000002
2025-11-10
Form 10-Q
ID: 0001933414-25-000142
2025-11-10
Form 8-K
ID: 0001933414-25-000139
2025-09-03
Form 8-K
ID: 0001933414-25-000120
2025-09-02
Form 8-K
ID: 0001933414-25-000107
2025-08-12
Form 10-Q
ID: 0001933414-25-000090
2025-08-12
Form 8-K
ID: 0001933414-25-000088
2025-06-17
Form 8-K
ID: 0001933414-25-000070
2025-05-22
Form 8-K
ID: 0001933414-25-000064